Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploring Eye Vergence Markers in Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).

NCT06885060 is registered in ClinicalTrials.gov with Elizabeth Kilbey as lead sponsor.

NCT NCT06885060
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06885060 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploring Eye Vergence Markers in Attention Deficit Hyperactivity Disorder (ADHD) and Autism Spectrum Disorder (ASD).
Lead sponsor
Elizabeth Kilbey
Phase
Observational
Overall status
Active, not recruiting
Start date
February 1, 2025
Completion date
January 31, 2027
Enrollment
200 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

attention deficit hyperactivity disorder (adhd), autism spectrum disorder (asd)